We provide 1 form of Ouabain
Ouabain
630-60-4
|
584.283
|
-1.901
Ouabain, a cardiac glycoside similar to digitoxin, is used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. Ouabain inhibits the Na-K-ATPase membrane pump, resulting in an increase in intracellular sodium and calcium concentrations.
O3125 | OUA | [3H]-ouabain | g-strophanthin | ouabain | quabain | strodival
Ouabain, a cardiac glycoside similar to digitoxin, is used to treat congestive heart failure and supraventricular arrhythmias due to reentry mechanisms, and to control ventricular rate in the treatment of chronic atrial fibrillation. Ouabain inhibits the Na-K-ATPase membrane pump, resulting in an increase in intracellular sodium and calcium concentrations.
O3125 | OUA | [3H]-ouabain | g-strophanthin | ouabain | quabain | strodival
$84/5 mg
(EBC)
1
We provide 0 compound for Ouabain